TOKYO -- Japanese drugmakers are joining forces with information technology companies and research institutions to create a government-backed consortium aimed at using artificial intelligence to discover new drugs more efficiently.
Among the roughly 50 corporations joining the initiative, due to kick off soon, are Takeda Pharmaceutical, Fujifilm Holdings, Shionogi & Co., Fujitsu and NEC. The government-affiliated Riken institute and Kyoto University will also take part, as will IT companies and drugmakers from abroad.
